Expression of RFC/SLC19A1 is Associated with Tumor Type in Bladder Cancer Patients

• Alyaa M. Abdel-Haleem ,

  * E-mail: alyaa.abdelhaleem@guc.edu (AMA-H); egspahnlan@uni-graz.at (HS-L)

  Affiliation Department of Pharmacology and Toxicology, German University in Cairo, Cairo, Egypt

  ⨯
• Maha I. El-Zeiry,

  Affiliation Department of Pharmacology and Toxicology, German University in Cairo, Cairo, Egypt

  ⨯
• Laila G. Mahran,

  Affiliation Department of Pharmacology and Toxicology, German University in Cairo, Cairo, Egypt

  ⨯
• Khaled Abou-Aisha,

  Affiliation Department of Pharmacology and Toxicology, German University in Cairo, Cairo, Egypt

  ⨯
• Mona H. Rady,

  Affiliation Department of Pharmacology and Toxicology, German University in Cairo, Cairo, Egypt

  ⨯
• Jan Rohde,

  Current address: Minapharm Pharmaceuticals, Rhein-Minapharm Biogenetics, 10th of Ramadan City, Egypt

  Affiliation Department of Pharmacology and Toxicology, German University in Cairo, Cairo, Egypt

  ⨯
• Marwa Mostageer,

  Current address: Discovery Department, AFFiRiS AG, Vienna, Austria

  Affiliation Department of Pharmacology and Toxicology, German University in Cairo, Cairo, Egypt

  ⨯
• Hilde Spahn-Langguth

  * E-mail: alyaa.abdelhaleem@guc.edu (AMA-H); egspahnlan@uni-graz.at (HS-L)

  Affiliations Department of Pharmacology and Toxicology, German University in Cairo, Cairo, Egypt, Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria

  ⨯